CRISPR Screen Reveals Key microRNA Driving Prostate Cancer Survival
A comprehensive CRISPR screening approach has uncovered microRNA-483-3p as a critical survival factor in prostate cancer cells. The findings reveal a previously unknown signaling network that controls programmed cell death, potentially explaining why some tumors resist conventional treatments. The discovery points toward new combination therapy strategies for advanced prostate cancer.
Breakthrough in Prostate Cancer Research
Scientists have identified a specific microRNA that appears to play a surprisingly central role in keeping prostate cancer cells alive, according to recent research findings. Using advanced CRISPR screening technology, researchers discovered that microRNA-483-3p functions as a master regulator of apoptosis—the programmed cell death process that typically eliminates damaged cells.